Pharmabiz21m
Dr Agarwals Eye Hospital notes 15-20% of total impaired vision in Karnataka due to corneal blindness
Our Bureau, Bengaluru Thursday, October 24, 2024, 17:30 Hrs [IST] ...
Pharmabiz30m
Thermo Fisher Scientific & Telangana government partner to set-up bioprocess design centre to advance novel biotherapeutics in India
Our Bureau, Bengaluru Thursday, October 24, 2024, 17:20 Hrs [IST] ...
Pharmabiz40m
Strides in Q2FY25 reports revenues Rs. 1,201.1 crore up 17% PAT Rs. 93.7 crore
Strides in Q2FY25 reports revenues Rs. 1,201.1 crore up 17% PAT Rs. 93.7 crore: Our Bureau, Bengaluru Thursday, October 24, 2024, 17:10 Hrs [IST] Strides Pharma Science in its Q2 ...
Pharmabiz50m
AIRS Medical & HealthCare Konnect partner to revolutionize MRI efficiency in Switzerland with SwiftMR
AIRS Medical & HealthCare Konnect partner to revolutionize MRI efficiency in Switzerland with SwiftMR: Seoul, Republic of Korea Thursday, October 24, 2024, 17:00 Hrs [IST] AIRS Me ...
Pharmabiz2h
Quest Diagnostics awarded US CDC contracts for H5 avian influenza and Oropouche virus test development
Quest Diagnostics awarded US CDC contracts for H5 avian influenza and Oropouche virus test development: Secaucus, New Jersey Thursday, October 24, 2024, 15:00 Hrs [IST] Quest Diag ...
Pharmabiz3h
Janssen-Cilag’s Darzalex -SC based quadruplet regimen gets European approval to treat patients with newly diagnosed MM who are transplant-eligible
Janssen-Cilag’s Darzalex -SC based quadruplet regimen gets European approval to treat patients with newly diagnosed MM who are transplant-eligible: Beerse, Belgium Thursday, Oct ...
Pharmabiz3h
JB Pharma outlines key ESG goals and targets in its Third Sustainability Report FY24
JB Pharma outlines key ESG goals and targets in its Third Sustainability Report FY24: Our Bureau, Mumbai Thursday, October 24, 2024, 14:30 Hrs [IST] J B Chemicals & Pharmaceutical ...
Pharmabiz1h
Pfizer receives US FDA approval for its RSV vaccine Abrysvo for adults aged 18 to 59 at increased risk for disease
Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, for the ...
Pharmabiz4h
NIHR awards nearly £17 million for global health research projects
The NIHR has awarded nearly £17 million to four new global health research projects. The projects aim to carry out targeted research to prevent, treat and manage multiple long-term conditions (MLTC) ...
Pharmabiz19h
Find Therapeutics initiates patient dosing in phase 1 study of FTX-101
Find Therapeutics, clinical-stage biopharmaceutical company, announced initiation of dosing in its phase 1 clinical study of FTX-101 in healthy volunteers. FTX-101 is a first-in-class therapeutic ...
Pharmabiz1d
Nuclidium announces first patient imaged in phase 1 study evaluating 61Cu-based radiotracer in patients with PSMA-positive
Nuclidium announced that the first patient has been successfully imaged in a phase 1 clinical trial evaluating the company’s radiotracer candidate as a safe and accurate diagnostic and disease-staging ...
Pharmabiz5h
Mankind Pharma completes acquisition of BSV to strengthen its leadership in women’s health
Mankind Pharma completes acquisition of BSV to strengthen its leadership in women’s health: Our Bureau, Benngaluru Thursday, October 24, 2024, 12:15 Hrs [IST] Mankind Pharma has ...